Safety, efficacy, and immunogenicity of adjuvant therapy with personalized cancer vaccine (PCV) RGL-270 in combination with adebrelimab and mFOLFIRINOX in resectable pancreatic ductal adenocarcinoma (PDAC).
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Si Shi, Jin Xu, Miaoyan Wei, Jialin Li, Nan Du, Cheng Liao, Qiuqiong Yu, Yiwu Du, Lei Song, Huanyu Wang, Xianjun Yu
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7162509837
Cites:
Cited by:
Related to: